Selskabets formål er er at drive virksomhed som speciallæge og virksomhed, der er naturligt forbundet hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 4.5 mio. | 1.5 mio. | 2.5 mio. | 1.9 mio. | 2 | |
CVR: 30522850
Secondary names: TETZSCHNER ApS
Compared to 625 companies in Speciallægers aktiviteter
Comparison is based on industry median values
The financial health of SPECIALLÆGESELSKABET TETZSCHNER ApS appears stable, though there is a noticeable decline in both revenue and profit in 2024, with revenue at 4,508,135 DKK and profit at 1,474,973 DKK, down from 5,169,102 DKK and 1,650,580 DKK in 2023. Over the past few years, revenue has shown fluctuations, peaking at 5,169,102 DKK in 2023, while profit margins have decreased, indicating potential challenges in maintaining profitability. The company's equity has also significantly decreased from 9,245,351 DKK in 2022 to 1,900,768 DKK in 2024, raising concerns about its long-term financial stability. Positioned within the specialized medical services industry, the company has demonstrated resilience, but the recent trends suggest a need for strategic adjustments to enhance its financial trajectory.
AI-generated summary
Companies in the same industry and area
companydata.dk